Salonpas and Metformin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Salonpas (menthol; methyl salicylate) and Metformin (metformin hydrochloride). Common drug interactions include drug ineffective among females and application site pain among males.

The phase IV clinical study analyzes what interactions people have when they take Salonpas and Metformin. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Salonpas?

Salonpas has active ingredients of menthol; methyl salicylate. eHealthMe is studying from 630 Salonpas users. Check the latest studies of Salonpas.

What is Metformin?

Metformin has active ingredients of metformin hydrochloride. It is often used in diabetes. eHealthMe is studying from 465,354 Metformin users. Check the latest studies of Metformin.

On Jul, 27, 2026

26 people who take Salonpas and Metformin together, and have interactions are studied.

Salonpas and Metformin drug interactions.

What are the common drug interactions of Salonpas and Metformin, by gender? *:

female:

Drug ineffective
Chronic left ventricular failure (long lasting functional impairment of left ventricle of heart)
Dry eye (lack of adequate tears)
Renal disorder (kidney disease)
Application site rash
Weight decreased
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Pain
Application site burn
Application site erythema (redness of the skin at application site)

male:

Application site pain
Back pain
Neck injury
Neck pain
Pain
Pain in extremity
Peripheral coldness
Poor quality sleep
Respiratory disorder (respiratory disease)
Application site erythema (redness of the skin at application site)

What are the common drug interactions of Salonpas and Metformin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Application site burn
Application site erythema (redness of the skin at application site)
Application site pain
Application site scar
Cellulitis (infection under the skin)
Chemical injury
Diabetic ulcer
Drug ineffective
Dry gangrene (diminished blood supply due to vascular problems)
Eschar (dead tissue that falls off (sheds) from healthy skin)

50-59:

Hypersensitivity
Malaise (a feeling of general discomfort or uneasiness)
Nasopharyngitis (inflammation of the nasopharynx)
Overdose
Respiratory depression (respiration has a rate below 12 breaths)

60+:

Pain
Fatigue (feeling of tiredness)
Infusion related reaction
Nasopharyngitis (inflammation of the nasopharynx)
Neck injury
Neck pain
Pain in extremity
Peripheral coldness
Poor quality sleep
Respiratory disorder (respiratory disease)

What are the existing conditions these people have? *

Pain: 7 people, 26.92%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 15.38%
High Blood Pressure: 3 people, 11.54%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 11.54%
Immunodeficiency Common Variable: 2 people, 7.69%
High Blood Cholesterol: 2 people, 7.69%
Erection Problems: 2 people, 7.69%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Salonpas and Metformin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously